The largest database of trusted experimental protocols

8 protocols using o 1602

1

Microglia Activation and Receptor Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
KIT C and KIT H were synthesized as described previously [17 (link)] by the Karlsruher Institute for Technology (KIT), Institute of Organic Chemistry, dissolved in DMSO (Merck KGaA, Darmstadt, Germany) and used in final concentrations of 0.1–25 µM. The GPR55 agonist O-1602 and GPR55 antagonist ML 193 (both from Cayman Chemicals, Ann Arbor, MI, USA, distributed by BioMol, Hamburg, Germany) were dissolved in DMSO and used in final concentrations of 5 µM (O-1602) and 25 µM (ML 193). Human interleukin (IL)-1β (100,000 U/mL in phosphate buffered saline (PBS)) was purchased from Roche Diagnostics (Manheim, Germany) and was used at a final concentration of 10 U/mL for the experiments. 5 mg/mL lipopolysaccharide (LPS) from Salmonella typhimurium (Sigma-Aldrich GmbH, Taufkirchen, Germany) was dissolved in PBS as stock and diluted with distilled water for a final concentration of 10 ng/mL in primary microglia cultures.
Figure 9 shows the chemical structure of KIT C and KIT H that were already introduced in a previous paper [17 (link)], as well as the structures of O-1602 and ML 193 obtained from the manufacturer’s (Cayman Chemicals, Ann Arbor, MI, USA) website.
+ Open protocol
+ Expand
2

Regulation of Lipid Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Arachidonic acid (20:4,n-6), essentially fatty acid-free bovine serum albumin (BSA), and lysophosphatidic acid (LPA) (1-oleoyl) sodium salt were obtained from Sigma (St. Louis, MO, USA). 1,2-Dipalmitoyl PI and 1,2-dioleoyl PI were from Avanti Polar Lipids, Inc. (Alabaster, AL, USA).
CP55940 and Y-27632 were from Tocris (Bristol, UK). WIN55212-2 was obtained from RBI (Natick, MA, USA). O-1602 was obtained from Cayman Chemical Co. (Ann Arbor, MI, USA). PD98059, SB203580, and SP600215 were acquired from Calbiochem-Novabiochem (San Diego, CA, USA). Wortmannin was obtained from Wako Pure Chem. Ind. (Osaka, Japan). Clostridium botulinum C3 exoenzyme pcDNA4/TO and LipofectamineTM 2000 were from Invitrogen Life Technologies (Carlsbad, CA, USA). The anti-RhoA 26C4 mouse monoclonal antibody was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). The anti-mouse IgG horseradish-peroxidase-linked goat antibody was obtained from Medical & Biological Laboratories Co, Ltd. (Nagoya, Japan). Lipase (Rhizopus delemar) was acquired from Seikagaku Kogyo Co., Ltd. (Tokyo, Japan).
+ Open protocol
+ Expand
3

Cannabinoid Receptor Ligand Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
CP55,940 and O-1602 were purchased from Cayman Chemicals (Ann Arbor, MI, USA). [3H]CP55,940 (174.6 Ci/mmol) was obtained from PerkinElmer (Guelph, ON, Canada). Unless stated, all other reagents were obtained from Sigma-Aldrich (Oakville, ON, Canada). Compounds were dissolved in DMSO (final concentration of 0.1% in assay media for all assays) and added directly to the media at the concentrations and times indicated.
+ Open protocol
+ Expand
4

Investigating GPR55 Signaling in Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal IgE (clone SPE7), RPMI 1640, 2-mercaptoethanol (2-ME), Laemmli buffer, L-α-lysophosphatidylinositol (LPI), and sphingosine-1-phosphate (S1P) were purchased from Sigma-Aldrich (St. Louis, MO, USA). HEPES, non-essential amino acids (NEAA), penicillin, streptomycin, and fetal bovine serum (FBS) were obtained from Gibco-BRL-Life Technologies (Gaithersburg, MD, USA). Interleukin (IL)-3 was purchased from PeproTech (Rocky Hill, NJ, USA). The GPR55 synthetic agonist, O-1602, was purchased from Cayman Chemical (Ann Arbor, MI, USA), while the GPR55 antagonist, ML-193, was purchased from TOCRIS (Bristol, UK). The CB2 antagonist, AM630, was from Sigma-Aldrich (St. Louis, MO, USA). Anti-p-cofilin (pSer 3) antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). Anti-p-LIMK (pThr 508/505) and anti-β-actin (C-terminal) antibodies were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). The secondary antibodies, HRP-coupled anti-mouse and anti-rabbit, were obtained from Jackson ImmunoResearch (West Grove, PA, USA). Rhodamine-labeled phalloidin and calcein-AM were obtained from Life Technologies (Carlsbad, CA, USA). DAPI was purchased from Invitrogen (Carlsbad, CA, USA). The polycarbonate filters were from Neuro Probe, and bovine skin gelatin from Sigma-Aldrich (St. Louis, MO, USA)
+ Open protocol
+ Expand
5

Paclitaxel and Cannabinoid Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paclitaxel and thiazolyl blue methyltetrazolium bromide (MTT) were obtained from Millipore-Sigma and dimethyl sulfoxide (DMSO) from Fisher BioReagents. O-1602 and abnormal CBD were obtained from Cayman Chemical Company. For all experiments, the drugs were dissolved in DMSO. The structures of cannabinoids used in this study were drawn using ChemDraw Prime 16.0.
+ Open protocol
+ Expand
6

Cannabinoid Receptor Agonist and Antagonist Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cocaine, nicotine and Δ9-THC was provided by the NIDA pharmacy (Baltimore, MD). O-1602 was supplied by Cayman Chemical (Cat#: 10006803). The selective GPR55 antagonist CID 16020046 (CID, Cat#: 4959) and Tocrifluor T1117 were purchased from Tocris Bioscience. For the more in detail, please see Supplmentary Information.
+ Open protocol
+ Expand
7

C2C12 Myoblast Differentiation and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12 cells were a kind gift from Professor David Cameron-Smith (Deakin University, Melbourne, Australia). Mouse-derived C2C12 myoblasts were cultured in Dulbecco’s modified eagle high glucose growth medium (D-MEM) supplemented with 10% foetal bovine serum (v/v), 1% penicillin streptomycin (v/v), 0.5% amphotericin B (v/v) and incubated at 37°C, 5% CO2 in a humidity controlled environment as previously described [39 (link)]. C2C12 myoblasts were seeded into 6 well plates and differentiated into myotubes (within ~72 h) via supplementation with 2% horse serum (v/v), 1% penicillin streptomycin (v/v), 0.5% amphotericin B (v/v) [39 (link)]. C2C12 cells were serum starved in 0.1% BSA (w/v) and a D-MEM solution for six hours prior to treatment, then treated for 24 h with vehicle (0.1% ethanol; Sigma Aldrich, St Louise, MO, USA) (n = 8–9) or O-1602 (10 nM–1000 nM; Cayman Chemical, Ann Arbor, Michigan, USA) (n = 9) or O-1918 (100nM; Cayman Chemical, Ann Arbor, Michigan, USA) (n = 8) and all treatments were dissolved in 0.1% ethanol and suspended in a 0.1% BSA and a D-MEM solution. Following treatment, cells were washed with ice cold PBS; then lysed, on ice with TRIzol Reagent® (Invitrogen, Victoria, Australia) and stored at −80 °C for subsequent RNA extraction.
+ Open protocol
+ Expand
8

Cannabinoid Ligand Preparation and Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
AEA, O-1602 and AbnCBD were purchased from Cayman Chemical Company (Ann Arbor, MI, USA). NAGly was bought from both Cayman and Enzo Biosciences (in order to exclude the possibility that lack of responses were related to a specific company’s synthesis/production; results were equivalent for both suppliers). Forskolin, CP55, 940, SR141716A, AM251 and AM630 were purchased from Tocris Bioscience (Bristol, UK). Phorbol-12-myristate-13 acetate (PMA) was purchased from Sigma Aldrich (St Louis, MO, USA). U0126 was purchased from Cell Signaling Technology (Danvers, MA, USA). All cannabinoid and lipid ligands were diluted in ethanol prior to storage in single use aliquots at −80 °C. The lipophilic properties of cannabinoids and lipid ligands such as NAGly cause them to adsorb onto the hydrophobic surfaces of plasticware and interact with serum components. To sustain drug availability in assays, the vessels in which cannabinoids were diluted were silanised (Coatasil, ThermoFisher AJA2293; Waltham MA, USA) and autoclaved prior to use, and assay media or HBSS were supplemented with 1 mg/ml bovine serum albumin (BSA, MP Biomedicals ABRE, Santa Ana, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!